Latest filing published 09 Jul 2026 for Ionis Pharmaceuticals INC, €27k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Holly B. Kordasiewicz is a declared insider of Ionis Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 15 January 2026 to 7 July 2026.
Sales make up the whole of the open-market record (1 sale, €27k). Outside the open market, there are 1 option exercise.
On 9 July 2026 came the latest disclosure, an open-market sale for €27k in Ionis Pharmaceuticals Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration